Komori
Statutory disclosure document7979SHOFU INC.Electrical Equipment and Precision Instruments

Statutory Advance Disclosure Document (Merger) (松風バイオフィックス株式会社)

SHOFU INC. has decided to absorb 松風バイオフィックス株式会社 in an absorption-type merger, with the merger scheduled to take effect on 1 October 2026. As this is a merger between a wholly owned parent company and its wholly owned subsidiary, no merger consideration will be issued.

Worth reading
69In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Decision and Details

The boards of directors of both companies

Absorption-type merger between SHOFU INC. and 松風バイオフィックス株式会社

Decision9 July 2026 (date the merger agreement was executed)
Period CoveredOn or after 1 October 2026 (after the effective date)
Implementation1 October 2026 (scheduled effective date)
Going forwardThe absorption-type merger is scheduled to take effect on 1 October 2026. If any particulars change after the start date of the advance disclosure, the revised particulars will be disclosed immediately.
AmountMerger consideration: none
Reason

Because this is a merger between a wholly owned parent company and its wholly owned subsidiary

Impact on Business Performance

No event that would impede the surviving company's ability to perform its obligations is currently anticipated with respect to its earnings or cash flow position.

Decision and Details
ItemDetails
Matter CoveredAbsorption-type merger between SHOFU INC. and 松風バイオフィックス株式会社
Decision-Making BodyThe boards of directors of both companies
Decision Date9 July 2026 (date the merger agreement was executed)
Implementation Date1 October 2026 (scheduled effective date)
Period CoveredOn or after 1 October 2026 (after the effective date)
AmountMerger consideration: none
Impact on Business PerformanceNo event that would impede the surviving company's ability to perform its obligations is currently anticipated with respect to its earnings or cash flow position.
ReasonBecause this is a merger between a wholly owned parent company and its wholly owned subsidiary
Governing RuleArticle 794, paragraph 1 of the Companies Act; Article 191 of the Ordinance for Enforcement of the Companies Act; Article 782, paragraph 1 of the Companies Act; Article 182 of the Ordinance for Enforcement of the Companies Act; Article 796, paragraph 2 of the Companies Act; and Article 784, paragraph 1 of the Companies Act
Future plansThe absorption-type merger is scheduled to take effect on 1 October 2026. If any particulars change after the start date of the advance disclosure, the revised particulars will be disclosed immediately.
Items this document does not state (2)
Quantity / scaleRelated previous disclosures

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

As this is a merger between a wholly owned parent company and its wholly owned subsidiary, no merger consideration will be issued. The company also states that, after the effective date, the surviving company's assets are expected to continue to substantially exceed its liabilities, and no event that would impede the performance of its obligations from an earnings or cash flow perspective is currently anticipated.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Statutory Advance Disclosure Document (Merger) (松風バイオフィックス株式会社) | SHOFU INC. (7979) timely disclosure | Komori